Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/2014
10/02/2014WO2014160710A1 Enterococcus faecalis bacteriophage and uses thereof
10/02/2014WO2014160475A1 Tropic cell based virotherapy for the treatment of cancer
10/02/2014WO2014159940A1 Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor
10/02/2014WO2014157778A1 Vector for producing serotype 6 recombinant adenovirus
10/02/2014WO2014153674A1 Influenza virus-like particle production in plants
10/02/2014US20140296504 Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
10/02/2014US20140295528 Novelpolypeptides and bacteriophages specific to klebsiella pneumoniae capsular type strains
10/02/2014US20140295409 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
10/02/2014US20140294891 Microorganisms for therapy
10/02/2014US20140294890 Recombinant Adenovirus Vaccines
10/02/2014US20140294763 Peptidomimetic protease inhibitors
10/01/2014EP2782997A1 Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
09/2014
09/30/2014US8846891 Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1)
09/30/2014US8846389 AAV4 vector and uses thereof
09/30/2014US8846388 Infectious clones of torque teno virus
09/30/2014US8846385 Method and means for producing high titer, safe recombinant lentivirus vectors
09/30/2014US8846368 Bacteriophage and antibacterial composition comprising the same
09/30/2014US8846203 Method of making ligand functionalized substrates
09/30/2014US8846055 Virulence determinant within the E2 structural glycoprotein of classical swine fever virus
09/30/2014US8846051 Modulation of replicative fitness by deoptimization of synonymous codons
09/30/2014US8846032 MDCK cell lines supporting viral growth to high titers and bioreactor process using the same
09/30/2014US8846031 Simian adenovirus 41 and uses thereof
09/30/2014US8846030 Compounds and methods to enhance rAAV transduction
09/25/2014WO2014153052A2 Cftr mrna compositions and related methods and uses
09/25/2014WO2014152231A1 Methods and compositions for bacteriophage therapy
09/25/2014WO2014151341A1 Compositions and methods for treating mpsi
09/25/2014WO2014151265A1 Methods and compositions for stimulating immune response
09/25/2014WO2014150870A2 Bacteriophage and methods of making and using
09/25/2014WO2014148738A1 Novel korean-type porcine reproductive and respiratory syndrome (prrs) virus
09/25/2014WO2014147063A1 Bacteriophages against salmonella ssp and their use
09/25/2014WO2014146933A1 A method for producing a product (e.g. polypeptide) in a continuous cell culture fermentation process.
09/25/2014US20140286983 Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
09/25/2014US20140286980 Infectious clones of torque teno virus
09/25/2014US20140286979 Canine influenza recombinant virus, preparation method therefor and application thereof
09/24/2014EP2781596A1 Methods for producing prepartions of recombinant AAVvirions substantially free of empty capsids
09/24/2014EP2781220A1 Bacteriophages against Salmonella and their use
09/24/2014EP2780447A1 Novel isolated bacteriophage having e. coli-specific bactericidal activity and antibacterial composition comprising the same
09/23/2014US8841433 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
09/18/2014WO2014145740A1 Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase)
09/18/2014WO2014145578A1 Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture system
09/18/2014WO2014145290A1 Attenuated influenza viruses and vaccines
09/18/2014WO2014143932A1 Synthetic adeno-associated virus inverted terminal repeats
09/18/2014WO2014142433A1 Cell strain having increased virus production ability and production method therefor
09/18/2014WO2014142235A1 Microvesicle, and manufacturing method for same
09/18/2014WO2014140641A1 Hiv viral load testing
09/18/2014WO2014140190A1 Rsv vaccines
09/18/2014WO2014138825A1 Immunogenic compositions and a process for producing same
09/18/2014WO2014138824A1 Immune modulation
09/18/2014US20140274808 Digital to biological converter
09/18/2014US20140274806 Influenza virus reassortment
09/18/2014US20140261478 Bacteriophage and methods of making and using
09/17/2014EP2776567A2 Compositions and methods for treatment of cytomegalovirus
09/17/2014EP2776559A1 Novel bacteriophages
09/17/2014EP2776063A1 Influenza virus -like particles (vlps) comprising hemagglutinin produced nicotiana tabacum
09/16/2014US8835107 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics
09/16/2014US8834893 Nucleic acid derived from hepatitis C virus and expression vector, transformed cell, and hepatitis C virus particles each prepared by using the same
09/16/2014US8834892 Method of preparing live viral vaccines by genetic engineering of viral genome
09/16/2014US8834863 Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
09/15/2014CA2809714A1 Infectious genomic dna clone and serological profile of torque teno sus virus 1 and 2
09/12/2014WO2014135998A1 In vitro and in vivo delivery of genes and proteins using the bacteriophage t4 dna packaging machine
09/11/2014US20140256957 N-Maleimidyl Polymer Derivatives
09/11/2014US20140256019 Compositions and Methods for Inhibiting Viral Adhesion
09/11/2014US20140255447 Production of avian embryo cells
09/11/2014US20140255445 Synthetic viruses and uses thereof
09/11/2014US20140255442 Novel european prrsv strain
09/10/2014EP2774985A1 Simian adenovirus SAdV-43 and uses thereof
09/09/2014USRE45123 Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
09/09/2014US8828673 Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses
09/09/2014US8828407 Chimaeric protein
09/09/2014US8828406 Influenza viruses and uses thereof
09/09/2014US8828405 Method to enhance an immune response of nucleic acid vaccination
09/09/2014CA2474032C Infectious clone of human parvovirus b19 and methods
09/04/2014WO2014134297A1 Covalent attachment of bacteriophages to polymeric surfaces
09/04/2014WO2014133323A1 Novel bacteriophage and antibacterial composition comprising the same
09/04/2014WO2014133322A1 Novel bacteriophage and antibacterial composition comprising the same
09/04/2014WO2014133301A1 Novel bacteriophage and antibacterial composition comprising the same
09/04/2014WO2014133290A1 Novel bacteriophage and antibacterial composition comprising the same
09/04/2014WO2014133289A1 Novel bacteriophage and antibacterial composition comprising the same
09/04/2014WO2014131898A1 A process for the production of adenovirus
09/04/2014WO2014131844A1 Vaccine against bovine leukemia virus
09/04/2014WO2014074535A9 Flavivirus envelope protein mutations affecting virion disassembly
09/04/2014US20140248695 Viral Vectors Purification System
09/04/2014US20140248243 Virus-like particles for treatment of viral infections
09/03/2014EP2771691A2 Sample quantification by disc centrifugation
09/03/2014EP2771456A1 Device and method for bacterial culture and assay
09/03/2014EP2771455A1 Cell line for production of adeno-associated virus
09/02/2014US8822641 Method for detecting and removing endotoxin
09/02/2014US8822192 Human rotavirus vaccine strains and diagnostics
09/02/2014US8821891 Live attenuated rotavirus vaccine for oral administration
09/02/2014US8821890 Influenza virus vaccine composition and methods of use
09/02/2014US8821889 West Nile Virus vaccine
09/02/2014US8821885 Immunogenic compositions and methods
09/02/2014US8821855 Methods for isolating phage and for controlling microorganism populations with the phage
08/2014
08/28/2014WO2014130454A1 Non-covalent loading of plant picornavirus particles
08/28/2014WO2014129964A2 Chromatographic purification of virus preparations with negatively charged particles
08/28/2014WO2014127478A1 Vaccine composition
08/28/2014US20140242671 Cell Line for Production of Adeno-associated Virus
08/28/2014US20140242670 Production of poliovirus at high titers for vaccine production
08/28/2014US20140242669 Production of infectious rna viruses in yeast
08/28/2014US20140242114 cDNA CONSTRUCT OF SALMONIDAE ALPHAVIRUS
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 267